Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carcinogenesis
|
355 | 0.724 | 0.280 | 17 | 72404025 | non coding transcript exon variant | C/T | snv | 0.16 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
cervical cancer
|
268 | 0.724 | 0.280 | 17 | 72404025 | non coding transcript exon variant | C/T | snv | 0.16 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Cervix carcinoma
|
283 | 0.724 | 0.280 | 17 | 72404025 | non coding transcript exon variant | C/T | snv | 0.16 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Hepatoblastoma
|
22 | 0.724 | 0.280 | 17 | 72404025 | non coding transcript exon variant | C/T | snv | 0.16 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Malignant neoplasm of stomach
|
615 | 0.724 | 0.280 | 17 | 72404025 | non coding transcript exon variant | C/T | snv | 0.16 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Malignant tumor of cervix
|
245 | 0.724 | 0.280 | 17 | 72404025 | non coding transcript exon variant | C/T | snv | 0.16 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Stomach Carcinoma
|
652 | 0.724 | 0.280 | 17 | 72404025 | non coding transcript exon variant | C/T | snv | 0.16 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Central neuroblastoma
|
231 | 0.724 | 0.280 | 17 | 72404025 | non coding transcript exon variant | C/T | snv | 0.16 | 0.020 | 1.000 | 2 | 2018 | 2019 | |||||
Childhood Kidney Wilms Tumor
|
36 | 0.724 | 0.280 | 17 | 72404025 | non coding transcript exon variant | C/T | snv | 0.16 | 0.020 | 0.500 | 2 | 2019 | 2019 | |||||
Childhood Neuroblastoma
|
231 | 0.724 | 0.280 | 17 | 72404025 | non coding transcript exon variant | C/T | snv | 0.16 | 0.020 | 1.000 | 2 | 2018 | 2019 | |||||
Malignant neoplasm of pancreas
|
277 | 0.724 | 0.280 | 17 | 72404025 | non coding transcript exon variant | C/T | snv | 0.16 | 0.020 | 1.000 | 2 | 2019 | 2019 | |||||
Neoplasms
|
1644 | 0.724 | 0.280 | 17 | 72404025 | non coding transcript exon variant | C/T | snv | 0.16 | 0.020 | 1.000 | 2 | 2018 | 2019 | |||||
Nephroblastoma
|
125 | 0.724 | 0.280 | 17 | 72404025 | non coding transcript exon variant | C/T | snv | 0.16 | 0.020 | 0.500 | 2 | 2019 | 2019 | |||||
Neuroblastoma
|
386 | 0.724 | 0.280 | 17 | 72404025 | non coding transcript exon variant | C/T | snv | 0.16 | 0.020 | 1.000 | 2 | 2018 | 2019 | |||||
Primary malignant neoplasm
|
1374 | 0.724 | 0.280 | 17 | 72404025 | non coding transcript exon variant | C/T | snv | 0.16 | 0.030 | 1.000 | 3 | 2019 | 2019 | |||||
Malignant Neoplasms
|
1641 | 0.724 | 0.280 | 17 | 72404025 | non coding transcript exon variant | C/T | snv | 0.16 | 0.040 | 1.000 | 4 | 2018 | 2019 | |||||
Pancreatic carcinoma
|
322 | 0.724 | 0.280 | 17 | 72404025 | non coding transcript exon variant | C/T | snv | 0.16 | 0.720 | 1.000 | 3 | 2015 | 2019 |